Highlights Nemaura Medical Inc.

Equities

NMRD

US6404422080

Delayed OTC Markets Other stock markets 15:19:18 2024-05-14 EDT			5-day change	1st Jan Change
0.0318 ^USD	+2.12%		-4.50%	-85.48%

04-10	Nemaura Medical Inc. Announces Board Changes	CI
02-12	Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Nemaura Medical Rolls Out Metabolic Health Program in UK	11-14	MT
Nemaura Medical Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs	11-14	CI
Nemaura Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-13	CI
Nemaura Medical Says Nasdaq Listing Standards Probably Won't Be Met by Deadline	23-09-14	MT
Nemaura Medical Announces Interim Results from Its Metabolic Health Program	23-09-13	CI
Nemaura Medical Completes 100 Patient Study for Sugarbeat® 24-Hour Wear and Reports Interim Results	23-09-11	CI
Nemaura Medical Inc. Announces SFDA Approval of SugarBEAT®	23-08-17	CI
Nemaura Medical Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Nemaura Medical Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-13	CI
Nemaura Medical, Inc. Announces Next Commercialization Stage of Its proBEAT Sensor	23-06-27	CI
Nemaura Medical Regains Compliance With Nasdaq Listing Rule	23-03-10	MT
Earnings Flash (NMRD) NEMAURA MEDICAL Posts Q3 Revenue $3,017	23-02-24	MT
Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-24	CI
Nemaura Medical Gets First Purchase Order for Glucose Sensors From HealthFleet; Shares Rise	23-01-26	MT
Nemaura Medical, Inc. Receives First Purchase Order from U.S. Health Provider HealthFleet	23-01-26	CI
Nemaura Medical, Inc. Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants	23-01-24	CI
Nemaura Medical, Inc. Commences Pilot Program of Miboko with the NHS in the United Kingdom	22-11-29	CI
Earnings Flash (NMRD) NEMAURA MEDICAL Reports Q2 Revenue $74,027	22-11-15	MT
Earnings Flash (NMRD) NEMAURA MEDICAL Reports Q2 Loss $-0.17	22-11-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nemaura Medical Inc.

Equities

NMRD

US6404422080

Highlights

Filters